1
|
Velasquez-Rodriguez JG, Maisterra S, Ramos R, Escobar I, Gornals JB. The Role of Endoscopic Ultrasound in the Interventional Management of Mediastinal Collections: A Narrative Review. Cureus 2022; 14:e27803. [PMID: 36106250 PMCID: PMC9452048 DOI: 10.7759/cureus.27803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/08/2022] [Indexed: 11/17/2022] Open
Abstract
The numerous causes underlying mediastinal lesions require different diagnostic and therapeutic approaches, including conservative, minimally invasive, and surgical interventions. Solid lesions of a malignant nature, mostly located in the anterior mediastinum, are properly treated with surgical resection either with or without adjuvant schemes. In contrast, a surveillance program is usually recommended with solid benign tumors, depending on their size and related symptomatology. In the management of mediastinal collections, when a drainage intervention is required (suspicion of infection and symptomatology), a minimally invasive nonsurgical procedure or thoracic surgery is considered. The minimally invasive nonsurgical procedures that can be available are percutaneous radiology-guided imaging (abdominal ultrasound (US) or computed tomography (CT) scan), complete single-aspiration guided by endoscopic ultrasound (EUS) or endobronchial ultrasound (EBUS), and transmural drainage guided by EUS. Surgical debridement is feasible to treat collections, but as this entails considerable risk of postoperative complications, it is chosen only when other minimally invasive therapies are not possible. The published literature related to the interventional endoscopic approach to mediastinal lesions is scarce. Nevertheless, reports in this field reveal that interventional EUS may have a role in both the diagnosis of and therapeutic approach to mediastinal lesions, mainly in the management of mediastinal collections.
Collapse
|
2
|
Zarogoulidis P, Huang H, Zhou J, Ning Y, Yang M, Wang J, Zhang R, Bai C, Shen X, Huang Z, Petridis D, Kosmidis C, Kosmidou M, Tsakiridis K, Hohenforst-Schmidt W, Baka S, Petanidis S, Zaric B, Kovacevic T, Stojsic V, Sarcev T, Bursac D, Kukic B, Rapti A, Pantea S, Rogoveanu O, Rogoveanu I, Romanidis K, Kesisoglou I, Ioannidis A, Vagionas A, Sapalidis K. Thyroid cancer diagnosis with transdermal probe 22G U/S versus EBUS-convex probe TBNA-B 22G and 19G: pros and cons. Expert Rev Med Devices 2021; 18:197-201. [PMID: 33482695 DOI: 10.1080/17434440.2021.1880891] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
INTRODUCTION Thyroid cancer is usually diagnosed both with imaging techniques and transdermal biopsy. Laboratory tests are also included in the initial work-up. PATIENTS AND METHODS One hundred and thirty patients were included in our study with pathological imaging findings in the thyroid region. Biopsies were performed with 22 G with transdermal convex probe, EBUS 22 G Mediglobe® needle and 19 G Olympus® needle. We investigated the efficiency and safety of both techniques and identified the best candidates for each method. DISCUSSION 19 G needle identified cancer types such as; Lymphoma, Medullary thyroid cancer, and Hurthle cell cancer, which we know from previous pathology studies that a larger sample is necessary for diagnosis. No safety issues were observed for both techniques and the EBUS technique produced more cell block material when 22 G needle was compared to transdermal biopsy in peritracheal lesions. CONCLUSION The method of biopsy should be made based on the size and accessibility of the lesion.
Collapse
Affiliation(s)
- Paul Zarogoulidis
- 3rdSurgery Department, Medical School of Health Sciences, ``AHEPA`` University Hospital, Thessaloniki, Greece
| | - Haidong Huang
- Department of Respiratory & Critical Care Medicine, Changhai Hospital, The Second Military Medical University, Shanghai, P. R. China
| | - Jun Zhou
- Department of Respiratory, Changzhou maternal and child health care hospital affiliated to Nanjing Medical University, Changzhou, Jiangsu Changzhou, China
| | - Yunye Ning
- Department of Respiratory & Critical Care Medicine, Changhai Hospital, The Second Military Medical University, Shanghai, P. R. China
| | - Meng Yang
- Department of Respiratory & Critical Care Medicine, Changhai Hospital, The Second Military Medical University, Shanghai, P. R. China.,Department of Geriatrics, Changhai Hospital, Second Military Medical University, Shanghai, China
| | - Jiannan Wang
- Department of Respiratory & Critical Care Medicine, Changhai Hospital, The Second Military Medical University, Shanghai, P. R. China
| | - Rong Zhang
- Department of Respiratory & Critical Care Medicine, Changhai Hospital, The Second Military Medical University, Shanghai, P. R. China
| | - Chong Bai
- Department of Respiratory & Critical Care Medicine, Changhai Hospital, The Second Military Medical University, Shanghai, P. R. China
| | - Xiaping Shen
- Department of Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China
| | - Zhiang Huang
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Henan University, Henan Kaifeng, China
| | - Dimitris Petridis
- Department of Food Technology, School of Food Technology and Nutrition, Alexander Technological Educational Institute, Thessaloniki, Greece
| | - Christoforos Kosmidis
- 3rdSurgery Department, Medical School of Health Sciences, ``AHEPA`` University Hospital, Thessaloniki, Greece
| | - Maria Kosmidou
- Internal Medicine Department, University of Ioannina, Ioannina, Greece
| | - Kosmas Tsakiridis
- Thoracic Surgery Department, ``Interbalkan`` European Medical Center, Thessaloniki, Greece
| | - Wolfgang Hohenforst-Schmidt
- Sana Clinic Group Franken, Department of Cardiology/Pulmonology/Intensive Care/Nephrology, "Hof" Clinics, University of Erlangen, Hof, Germany
| | - Sofia Baka
- Onc/ology Department, Interbalkan European Medical Center, Thessaloniki, Greece
| | - Savas Petanidis
- Department of Pulmonology, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
| | - Bojan Zaric
- Faculty of Medicine, University of Novi Sad, Institute for Pulmonary Diseases of Vojvodina, Novi Sad, Serbia
| | - Tomi Kovacevic
- Faculty of Medicine, University of Novi Sad, Institute for Pulmonary Diseases of Vojvodina, Novi Sad, Serbia
| | - Vladimir Stojsic
- Faculty of Medicine, University of Novi Sad, Institute for Pulmonary Diseases of Vojvodina, Novi Sad, Serbia
| | - Tatjana Sarcev
- Faculty of Medicine, University of Novi Sad, Institute for Pulmonary Diseases of Vojvodina, Novi Sad, Serbia
| | - Daliborka Bursac
- Faculty of Medicine, University of Novi Sad, Institute for Pulmonary Diseases of Vojvodina, Novi Sad, Serbia
| | - Biljana Kukic
- Faculty of Medicine, University of Novi Sad, Institute for Oncology of Vojvodina, Novi Sad, Serbia
| | - Aggeliki Rapti
- Pulmonary Oncology Department, ``sotiria`` Hospital of Chest Diseases, Athens, Greece
| | - Stelian Pantea
- 3rdSurgery Department, Medical School of Health Sciences, ``AHEPA`` University Hospital, Thessaloniki, Greece.,Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Henan University, Henan Kaifeng, China
| | - Otelia Rogoveanu
- Department of Medical Rehabilitation, University of Medicine and Pharmacy, Craiova, Romania
| | - Ion Rogoveanu
- Department of Medical Rehabilitation, University of Medicine and Pharmacy, Craiova, Romania
| | - Konstantinos Romanidis
- Second Department of Surgery, General University Hospital of Alexandroupolis, Medical School Democritus University of Thrace, Alexandroupolis, Greece
| | - Issak Kesisoglou
- 3rdSurgery Department, Medical School of Health Sciences, ``AHEPA`` University Hospital, Thessaloniki, Greece
| | - Aris Ioannidis
- Surgery Department, ``Genesis`` Private Hospital, Thessaloniki, Greece
| | | | - Konstantinos Sapalidis
- 3rdSurgery Department, Medical School of Health Sciences, ``AHEPA`` University Hospital, Thessaloniki, Greece
| |
Collapse
|
3
|
Bellido-Calduch S, Martín-Ontiyuelo C, Pijuan L, Puig de Dou J, Suárez-Piñera M, Curull V, Sánchez-Font A. Endoscopic Diagnosis of Small Cell Lung Carcinoma and Follicular Thyroid Cancer. Arch Bronconeumol 2020; 56:328-329. [PMID: 35373742 DOI: 10.1016/j.arbr.2019.11.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2019] [Accepted: 11/06/2019] [Indexed: 06/14/2023]
Affiliation(s)
- Salomé Bellido-Calduch
- Servei de Pneumologia, Hospital del Mar-Parc de Salut Mar, UAB, CIBERES, ISCIII, Barcelona, Spain
| | - Clara Martín-Ontiyuelo
- Servei de Pneumologia, Hospital del Mar-Parc de Salut Mar, UAB, CIBERES, ISCIII, Barcelona, Spain; IMIM, Hospital del Mar Medical Research Institute, Barcelona, Spain
| | - Lara Pijuan
- Servei d'Anatomia Patològica, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - Jaume Puig de Dou
- Servei d'Endocrinologia i Nutrició, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - Marina Suárez-Piñera
- Servei de Medicina Nuclear i Diagnòstic per Imatge, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - Víctor Curull
- Servei de Pneumologia, Hospital del Mar-Parc de Salut Mar, UAB, CIBERES, ISCIII, Barcelona, Spain; IMIM, Hospital del Mar Medical Research Institute, Barcelona, Spain
| | - Albert Sánchez-Font
- Servei de Pneumologia, Hospital del Mar-Parc de Salut Mar, UAB, CIBERES, ISCIII, Barcelona, Spain; IMIM, Hospital del Mar Medical Research Institute, Barcelona, Spain.
| |
Collapse
|
5
|
Role of Convex Probe Endobronchial Ultrasound in the Diagnosis and Treatment of Nonmalignant Diseases. Pulm Med 2019; 2019:6838439. [PMID: 31316830 PMCID: PMC6601475 DOI: 10.1155/2019/6838439] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2018] [Revised: 05/31/2019] [Accepted: 06/07/2019] [Indexed: 01/08/2023] Open
Abstract
Here we present a comprehensive review of the literature concerning the utility of convex probe endobronchial ultrasound (CP-EBUS) in the diagnosis and treatment of nonmalignant conditions and discuss the associated complications. CP-EBUS has been conventionally used for the staging of lung cancer and sampling of mediastinal and hilar nodes. However, its application is not limited to malignant conditions, and it is gaining acceptance as a diagnostic modality of choice for nonmalignant conditions such as tuberculosis, sarcoidosis, pulmonary embolism, thyroid lesions, and cysts. Moreover, its therapeutic value allows for extended applications such as mediastinal and thyroid cyst drainage, fiducial marker placement for radiation therapy, and transbronchial needle injection. The noninvasiveness, low complication rate, high diagnostic yield, and satisfactory sensitivity and specificity values are the main attributes that lend credence to the use of CP-EBUS as a standalone primary diagnostic and therapeutic tool in pulmonary medicine in the foreseeable future.
Collapse
|